Angelalign Technology to Challenge Court Ruling on Premolar Extraction Solutions in China
On August 12, 2026, Angelalign Technology Inc., listed on the Hong Kong Stock Exchange, declared its intention to challenge the August 10 ruling by the Jinan Intermediate People's Court in China. The court mandated that Angel's subsidiaries in the country cease using their masterForce biomechanics simulation and ATreat digital diagnosis systems, which are essential for generating A7 and A7 Speed premolar extraction solutions. Despite the urgency of this situation, the company reassured stakeholders that the ruling has no immediate impact on their existing customers or patients, as it has not yet taken effect.
Angelalign, a leader in digital clear aligner technology with a mission to enhance orthodontic practices globally, expressed strong confidence in its position, asserting that the A7 Premolar Extraction Solution does not violate any credible patents. This statement is supported by the fact that Angelalign has successfully navigated several patent disputes against the plaintiff in various legal jurisdictions. According to Fox Hu, the company's CEO, the court's decision is limited to China, and they are optimistic about their prospects of winning the appeal, especially given their track record of similar legal victories.
Previously, on May 12, 2026, the Unified Patent Court's Local Division Düsseldorf in Germany rejected the plaintiff's preliminary injunction against Angelalign with respect to the same A7 Premolar Extraction Solution, and the ruling remains final as the plaintiff did not appeal. It’s worth noting that the European and Chinese patents involved in the current case are linked, belonging to the same patent family. Moreover, the Zhengzhou Intermediate People's Court of China dismissed two patent infringement cases brought by the same plaintiff against Angelalign on June 26, 2026, asserting the validity of Angel's products while also noting that the plaintiff has appealed those judgments.
Angelalign has established a reputable position in the orthodontic field, with numerous professionals worldwide recognizing it as an authority in managing complex orthodontic cases. The company's history of innovation spans over two decades, strengthening their market presence. They pride themselves on maintaining respect for intellectual property while innovating, which has fostered trust among both customers and competitors.
With a market capitalization of $2 billion, Angelalign boasts a solid balance sheet and operational profitability, effectively positioning itself as a reliable, long-term ally for orthodontists intent on delivering exceptional clinical outcomes. The ongoing case is a segment of a broader legal battle involving Align Technology Inc. (ALGN), alleging patent infringement, a claim that Angelalign continues to resist. For further information and updates, stakeholders are encouraged to visit the company’s dedicated legal proceedings page on their website.
In conclusion, Angelalign's commitment to its customers during this legal hurdle signifies its perseverance and focus on continued growth and innovation. As they navigate these challenges, the company is poised to expand its services and products globally, striving to meet the evolving needs of dental professionals and patients alike. Angelalign remains resolute in its dedication to delivering the highest quality digital solutions in orthodontics, with numerous innovative products already acclaimed in the market, including the KiD aligner system and A6 Mandibular Advancement system. For dedicated orthodontists and engaged patients, this commitment to excellence ensures a promising future ahead.
Angelalign, a leader in digital clear aligner technology with a mission to enhance orthodontic practices globally, expressed strong confidence in its position, asserting that the A7 Premolar Extraction Solution does not violate any credible patents. This statement is supported by the fact that Angelalign has successfully navigated several patent disputes against the plaintiff in various legal jurisdictions. According to Fox Hu, the company's CEO, the court's decision is limited to China, and they are optimistic about their prospects of winning the appeal, especially given their track record of similar legal victories.
Previously, on May 12, 2026, the Unified Patent Court's Local Division Düsseldorf in Germany rejected the plaintiff's preliminary injunction against Angelalign with respect to the same A7 Premolar Extraction Solution, and the ruling remains final as the plaintiff did not appeal. It’s worth noting that the European and Chinese patents involved in the current case are linked, belonging to the same patent family. Moreover, the Zhengzhou Intermediate People's Court of China dismissed two patent infringement cases brought by the same plaintiff against Angelalign on June 26, 2026, asserting the validity of Angel's products while also noting that the plaintiff has appealed those judgments.
Angelalign has established a reputable position in the orthodontic field, with numerous professionals worldwide recognizing it as an authority in managing complex orthodontic cases. The company's history of innovation spans over two decades, strengthening their market presence. They pride themselves on maintaining respect for intellectual property while innovating, which has fostered trust among both customers and competitors.
With a market capitalization of $2 billion, Angelalign boasts a solid balance sheet and operational profitability, effectively positioning itself as a reliable, long-term ally for orthodontists intent on delivering exceptional clinical outcomes. The ongoing case is a segment of a broader legal battle involving Align Technology Inc. (ALGN), alleging patent infringement, a claim that Angelalign continues to resist. For further information and updates, stakeholders are encouraged to visit the company’s dedicated legal proceedings page on their website.
In conclusion, Angelalign's commitment to its customers during this legal hurdle signifies its perseverance and focus on continued growth and innovation. As they navigate these challenges, the company is poised to expand its services and products globally, striving to meet the evolving needs of dental professionals and patients alike. Angelalign remains resolute in its dedication to delivering the highest quality digital solutions in orthodontics, with numerous innovative products already acclaimed in the market, including the KiD aligner system and A6 Mandibular Advancement system. For dedicated orthodontists and engaged patients, this commitment to excellence ensures a promising future ahead.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.